Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$2.05 - $4.12 $2,406 - $4,836
-1,174 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$2.24 - $3.94 $4,538 - $7,982
-2,026 Reduced 63.31%
1,174 $3,000
Q3 2019

Nov 14, 2019

BUY
$2.8 - $6.05 $8,960 - $19,360
3,200 New
3,200 $8,000

Others Institutions Holding JAN

About JanOne Inc.


  • Ticker JAN
  • Exchange NASDAQ
  • Sector Industrials
  • Industry Waste Management
  • Shares Outstandng 3,150,230
  • Market Cap $6.49M
  • Description
  • JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. ...
More about JAN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.